From an immune response perspective, KLF5 negatively correlates with B-cell naïve, CD8+ T cells, and macrophage MO cells, suggesting that overexpression in the tumor microenvironment inhibits the immune system’s ability to fight cancer [181]. The gene discussed is KLF5; the disease is neoplasm.